Therapieoptimierungsstudie in der Primärtherapie des intermediären Hodgkin Lymphoms: Therapiestratifizierung mittels FDG-PET
Phase 1
- Conditions
- Hodgkin´s Lymhoma stage I, IIA mit RF a-dIIB mit RF c,dTherapeutic area: Diseases [C] - Cancer [C04]
- Registration Number
- EUCTR2007-005920-34-AT
- Lead Sponsor
- niversity of Cologne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 1100
Inclusion Criteria
Hodgkin Lymphom
Erstdiagnose, therapienaiv, histologisch gesichert, Alter: 18-60 Jahre
Stadium I, IIA mit RF a-d; Stadium IIB mit RF c,d (a: großer Mediastinaltumor, b: Extranodalbefall, c: hohe BSG, d: > 3 Lymphknotenareale)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 1100
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Composite Lymphoma
Maligne Vorerkrankung, vorausgegangene Chemo- oder Strahlentherapie
Begleiterkrankungen, die eine protokollgerechte Therapie unmöglich machen
Schwangerschaft/Stillen
mangelnde Compliance
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method